| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970143 | The Journal of Heart and Lung Transplantation | 2015 | 9 Pages |
Abstract
Reduction of de novo CNI did not result in superior long-term renal function. Low-dose mechanistic target of rapamycin inhibition did not achieve any benefit in CAV prevention compared with full-dose TAC/MMF after HTX.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sonja MD, Katja MD, Carola MD, Matthias A. MD, Eike C. DVM, Anna M.Sc., Tanja DVM, Franz MD, Bruno MD, Christian MD, René MD, Ingo MD, Bruno M. MD,